Lumen HomepageTechnologyPipelinePress
Company Overview
Scientific Advisory Board
Paul McGrane, PhD, Director and Founder
Dr. McGrane has sixteen years of experience in the research and development of pharmaceutical agents. He joined CellGate as its first hire in chemistry and assumed the lead role in development efforts at CellGate, with primary oversight of the outsourcing of the preclinical, CMC and clinical functions. From late 1994 through 1998 Dr. McGrane worked first for Pfizer (Groton, CT) and then for Roche Bioscience (Palo Alto, CA). His duties included the development of scalable processes for the manufacture of molecules of pharmaceutical interest. Previous to this, Dr. McGrane spent two years as a postdoctoral fellow at Stanford University where he played a vital role in designing and executing a total synthesis of the chemotherapeutic agent Taxol®. He received his PhD in chemistry from Montana State University and his B.S. degree in chemistry from the South Dakota School of Mines and Technology. Dr. McGrane is a Registered Patent Agent and one of Lumen's founders.

C. Garrison Fathman, MD, Director and Founder
Dr. Fathman is Professor of Medicine and Chief of the Division of Immunology and Rheumatology at Stanford University School of Medicine and is also director of the Center for Clinical Immunology at Stanford (CCIS). Dr. Fathman received his M.D. from Washington University in St. Louis and did his residency training at Dartmouth Affiliated Hospitals and a fellowship in immunology and rheumatology at Stanford University before completing an additional 4 years of basic immunology research at the NIH and Basel . He then joined the faculty at the Mayo Clinic in 1977 and was recruited to Stanford University in 1981. There he continues his seminal work on T cell activation and regulation in association with autoimmune diseases. Dr. Fathman has published over 250 articles in his field and is a member of many professional organizations, including the American Association of Immunologists and the Association of American Physicians, and is founding Chairman of the Federation of Clinical Immunology Societies (FOCIS). He was a co-founder of Cetus Immune, Immulogic and CellGate, and has served on the SAB of multiple companies.

Michael Danaher, JD, Director
Mike Danaher is a partner in the law firm of Wilson Sonsini Goodrich & Rosati, Michael Danaher works with private and public emerging growth companies in the life sciences and other high technology industries. He handles general corporate matters and transactions, including private financings, public offerings, mergers and acquisitions. Mr. Danaher graduated from Yale College in 1975 and from Stanford Law School in 1980.
© 2005-2010 Lumen Therapeutics   |   All rights reserved.   |